Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
22.21
-0.47 (-2.07%)
Mar 5, 2026, 4:00 PM EST - Market closed
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.78 billion as of March 5, 2026. Its market cap has increased by 138.53% in one year.
Market Cap
2.78B
Enterprise Value
1.99B
1-Year Change
138.53%
Ranking
Category
Stock Price
$22.21
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $2.78B, an increase of 295.16%. That is a compound annual growth rate of 18.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.78B | -5.58% |
| Dec 31, 2025 | 2.95B | 116.38% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 3.05B |
| Liquidia | 3.00B |
| Arcutis Biotherapeutics | 2.97B |
| Catalyst Pharmaceuticals | 2.97B |
| Viridian Therapeutics | 2.96B |
| IDEAYA Biosciences | 2.90B |
| Vera Therapeutics | 2.77B |
| Dianthus Therapeutics | 2.66B |